Application

18167168 · [1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS

Filed 2023-02-10 · Abandoned The official file ↗ · Art unit 1624 · Examiner Douglas M Willis Typical · CPC C07D 487/04 · Boehringer Ingelheim International GmbH · C/O VP, IP, LEGAL

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

11.5 mo

to disposition 19.1 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.